NASDAQ:SIENSientra Stock Price, Forecast & News

Sientra's stock was trading at $2.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SIEN shares have increased by 71.7% and is now trading at $4.19.
View which stocks have been most impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Sientra.

Sientra is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020.
View our earnings forecast for Sientra.

Sientra will be holding an earnings conference call on Monday, August 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Sientra Inc (NASDAQ:SIEN) issued its quarterly earnings results on Monday, May, 11th. The medical instruments supplier reported ($0.57) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.49) by $0.08. The medical instruments supplier earned $16.93 million during the quarter, compared to the consensus estimate of $18.70 million. Sientra had a negative net margin of 134.87% and a negative return on equity of 101.94%.
View Sientra's earnings history.

6 equities research analysts have issued 1 year price targets for Sientra's shares. Their forecasts range from $5.00 to $9.00. On average, they expect Sientra's share price to reach $6.46 in the next twelve months. This suggests a possible upside of 54.2% from the stock's current price.
View analysts' price targets for Sientra.

Press coverage about SIEN stock has trended very positive on Saturday, according to InfoTrie Sentiment. The research group rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Sientra earned a coverage optimism score of 4.0 on InfoTrie's scale. They also gave news coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days.
View the latest news about Sientra.

Sientra saw a decrease in short interest in July. As of July 31st, there was short interest totaling 3,750,000 shares, a decrease of 24.2% from the July 15th total of 4,950,000 shares. Based on an average trading volume of 1,770,000 shares, the short-interest ratio is currently 2.1 days. Currently, 8.7% of the shares of the company are sold short.
View Sientra's Short Interest.

Some companies that are related to Sientra include Inogen (INGN), Establishment Labs (ESTA), Invacare (IVC), RTI Surgical (RTIX), Lakeland Industries (LAKE), ConforMIS (CFMS), COLLPLANT HOLDI/S (CLGN), Histogenics (HSGX), Allied Healthcare Products (AHPI), Ocugen (OCGN), Rewalk Robotics (RWLK), Precision Therapeutics (POAI), Bionik Laboratories (BNKL), NanoVibronix (NAOV) and Avitar (AVTI).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sientra investors own include Micron Technology (MU), Oasis Petroleum (OAS), Advanced Micro Devices (AMD), Alibaba Group (BABA), Genocea Biosciences (GNCA), AT&T (T), Viking Therapeutics (VKTX), Verizon Communications (VZ), Anavex Life Sciences (AVXL) and salesforce.com (CRM).

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

Sientra's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include UBS Group AG (4.82%), Mutual of America Capital Management LLC (2.62%), Assenagon Asset Management S.A. (1.00%), SG Americas Securities LLC (0.05%), Wedbush Securities Inc. (0.02%) and Principal Financial Group Inc. (0.02%). Company insiders that own Sientra stock include Jeffrey M Nugent, Keith J Sullivan, Paul Sean Little and Timothy Haines.
View institutional ownership trends for Sientra.

SIEN stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, and SG Americas Securities LLC.
View insider buying and selling activity for Sientra.

SIEN stock was purchased by a variety of institutional investors in the last quarter, including Mutual of America Capital Management LLC, Assenagon Asset Management S.A., Wedbush Securities Inc., and Principal Financial Group Inc.. Company insiders that have bought Sientra stock in the last two years include Keith J Sullivan, and Paul Sean Little.
View insider buying and selling activity for Sientra.

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SIEN stock can currently be purchased for approximately $4.19.

Sientra has a market capitalization of $209.63 million and generates $83.70 million in revenue each year. The medical instruments supplier earns $-106,820,000.00 in net income (profit) each year or ($2.29) on an earnings per share basis. Sientra employs 339 workers across the globe.

The official website for Sientra is www.sientra.com.

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]